251 related articles for article (PubMed ID: 20020362)
1. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
Thevis M; Schänzer W
Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry of selective androgen receptor modulators.
Thevis M; Schänzer W
J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
[TBL] [Abstract][Full Text] [Related]
3. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure.
Fragkaki AG; Angelis YS; Koupparis M; Tsantili-Kakoulidou A; Kokotos G; Georgakopoulos C
Steroids; 2009 Feb; 74(2):172-97. PubMed ID: 19028512
[TBL] [Abstract][Full Text] [Related]
4. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
Yarrow JF; McCoy SC; Borst SE
Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
[TBL] [Abstract][Full Text] [Related]
5. Androgenic-anabolic steroids and the Olympic Games.
Fitch KD
Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
[TBL] [Abstract][Full Text] [Related]
6. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
[TBL] [Abstract][Full Text] [Related]
7. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
Bahrke MS; Yesalis CE
Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
[TBL] [Abstract][Full Text] [Related]
8. Sports-related issues and biochemistry of natural and synthetic anabolic substances.
Parr MK; Flenker U; Schänzer W
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):45-57, viii. PubMed ID: 20122449
[TBL] [Abstract][Full Text] [Related]
9. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
Omwancha J; Brown TR
Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
[TBL] [Abstract][Full Text] [Related]
10. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.
Thevis M; Thomas A; Kohler M; Beuck S; Schänzer W
J Mass Spectrom; 2009 Apr; 44(4):442-60. PubMed ID: 19373874
[TBL] [Abstract][Full Text] [Related]
11. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes.
Thevis M; Kamber M; Schänzer W
Rapid Commun Mass Spectrom; 2006; 20(5):870-6. PubMed ID: 16470709
[TBL] [Abstract][Full Text] [Related]
12. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
[TBL] [Abstract][Full Text] [Related]
13. Anabolic steroids: a fatal attraction?
Wood RI
J Neuroendocrinol; 2006 Mar; 18(3):227-8. PubMed ID: 16454806
[TBL] [Abstract][Full Text] [Related]
14. Selective androgen receptor modulators for frailty and osteoporosis.
Kilbourne EJ; Moore WJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2007 Oct; 8(10):821-9. PubMed ID: 17907058
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry of hydantoin-derived selective androgen receptor modulators.
Thevis M; Kohler M; Schlörer N; Kamber M; Kühn A; Linscheid MW; Schänzer W
J Mass Spectrom; 2008 May; 43(5):639-50. PubMed ID: 18095383
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
[TBL] [Abstract][Full Text] [Related]
17. Anabolic steroid-induced hypogonadism--towards a unified hypothesis of anabolic steroid action.
Tan RS; Scally MC
Med Hypotheses; 2009 Jun; 72(6):723-8. PubMed ID: 19231088
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
[TBL] [Abstract][Full Text] [Related]
19. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
Geyer H; Schänzer W; Thevis M
Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
[TBL] [Abstract][Full Text] [Related]
20. Effects of androgenic-anabolic steroids in athletes.
Hartgens F; Kuipers H
Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
